{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:21Z","timestamp":1792783101672,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["NO.22367014, NO.22167017"],"award-info":[{"award-number":["NO.22367014, NO.22167017"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Jiangxi, China","award":["No. 20242BAB23088"],"award-info":[{"award-number":["No. 20242BAB23088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11582-7","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:22:52Z","timestamp":1778757772000},"page":"6863-6882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, synthesis and pharmacological evaluation of novel 2-aryloxazole-based H3 receptor antagonists as potent, antiseizure agents"],"prefix":"10.1007","volume":"30","author":[{"given":"Ying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingna","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieya","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"11582_CR1","doi-asserted-by":"publisher","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","volume":"5","author":"CE Stafstrom","year":"2015","unstructured":"Stafstrom CE, Carmant L (2015) Seizures and epilepsy: an overview for neuroscientists, Cold Spring Harb. Perspect Med 5:a022426. https:\/\/doi.org\/10.1101\/cshperspect.a022426","journal-title":"Perspect Med"},{"key":"11582_CR2","doi-asserted-by":"publisher","first-page":"674483","DOI":"10.3389\/fneur.2021.674483","volume":"12","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso A, Matricardi S, Mencaroni E et al (2021) The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front Neurol 12:674483. https:\/\/doi.org\/10.3389\/fneur.2021.674483","journal-title":"Front Neurol"},{"key":"11582_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG (2012) Adverse effects of antiseizure drugs. Lancet Neurol 11:792\u2013802. https:\/\/doi.org\/10.1016\/S1474-4422(12)70153-9","journal-title":"Lancet Neurol"},{"key":"11582_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen Z, Brodie MJ, Liew D et al (2018) Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiseizure drugs: a 30-year longitudinal cohort study. JAMA Neurol 75:279\u2013286. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3949","journal-title":"JAMA Neurol"},{"key":"11582_CR5","doi-asserted-by":"publisher","first-page":"a022780","DOI":"10.1101\/cshperspect.a022780","volume":"6","author":"MA Rogawski","year":"2016","unstructured":"Rogawski MA, L\u00f6scher W, Rho JM (2016) Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med 6:a022780. https:\/\/doi.org\/10.1101\/cshperspect.a022780","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11582_CR6","doi-asserted-by":"publisher","unstructured":"Panula P, Chazot PL, Cowart M et al International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67 (2015) 601\u2013655, https:\/\/doi.org\/10.1124\/pr.114.010249","DOI":"10.1124\/pr.114.010249"},{"key":"11582_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","volume":"88","author":"HL Haas","year":"2008","unstructured":"Haas HL, Sergeeva OA, Selbach O (2008) Histamine in the nervous system. Physiol Rev 88:1183\u20131241. https:\/\/doi.org\/10.1152\/physrev.00043.2007","journal-title":"Physiol Rev"},{"key":"11582_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302:832\u2013837. https:\/\/doi.org\/10.1038\/302832a0","journal-title":"Nature"},{"key":"11582_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/164_2016_12","volume":"241","author":"E Schlicker","year":"2017","unstructured":"Schlicker E, Kathmann M (2017) Role of the histamine H3 receptor in the central nervous system. Handb Exp Pharmacol 241:277\u2013299. https:\/\/doi.org\/10.1007\/164_2016_12","journal-title":"Handb Exp Pharmacol"},{"key":"11582_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fnsys.2012.00072","volume":"6","author":"D Vohora","year":"2012","unstructured":"Vohora D, Bhowmik M (2012) Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: relevance to Alzheimer\u2019s disease, ADHD, schizophrenia, and drug abuse. Front Syst Neurosci 6:72. https:\/\/doi.org\/10.3389\/fnsys.2012.00072","journal-title":"Front Syst Neurosci"},{"key":"11582_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pharmthera.2017.04.004","volume":"178","author":"K Yanai","year":"2017","unstructured":"Yanai K, Yoshikawa T, Yanai A et al (2017) The clinical pharmacology of non-sedating antihistamines. Pharmacol Ther 178:148\u2013156. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.04.004","journal-title":"Pharmacol Ther"},{"key":"11582_CR12","first-page":"457","volume":"52","author":"C Silva","year":"1997","unstructured":"Silva C, Ficker H, Yassin M et al (1997) Plasma concentration and brain penetration of the H3 receptor antagonist thioperamide in rats. Il Farmaco 52:457\u2013462","journal-title":"Il Farmaco"},{"key":"11582_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/WNF.0000000000000159","volume":"39","author":"P Collart Dutilleul","year":"2016","unstructured":"Collart Dutilleul P, Ryvlin P, Kahane P et al (2016) Exploratory phase II trial to evaluate the safety and the antiepileptic effect of pitolisant (BF2.649) in refractory partial seizures, given as adjunctive treatment during 3 months. Clin Neuropharmacol 39:188\u2013193","journal-title":"Clin Neuropharmacol"},{"key":"11582_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neuropharm.2015.10.023","volume":"106","author":"B Sadek","year":"2016","unstructured":"Sadek B, Saad A, Subramanian D et al (2016) Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats. Neuropharmacology 106:46\u201355","journal-title":"Neuropharmacology"},{"key":"11582_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3389\/fphar.2017.00707","volume":"8","author":"B Sadek","year":"2017","unstructured":"Sadek B, Saad A, Schwed JS et al (2017) N-(3-(1-(Cyclohexylmethyl)piperidin-4-yl)propyl)-3-fluorobenzamide (SUVN-G3031): A novel, potent, selective, and orally active histamine H3 receptor inverse agonist for the treatment of narcolepsy. Front Pharmacol 8:707. https:\/\/doi.org\/10.3389\/fphar.2017.00707","journal-title":"Front Pharmacol"},{"key":"11582_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2016.02.001","volume":"105","author":"B Sadek","year":"2016","unstructured":"Sadek B, Saad A, Schwed JS et al (2016) Anticonvulsant and proconvulsant effects of histamine H3 receptor ligands in an animal model of pentylenetetrazole-induced seizures. Neuropharmacology 105:408\u2013417. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.001","journal-title":"Neuropharmacology"},{"key":"11582_CR17","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s40265-016-0620-1","volume":"76","author":"YY Syed","year":"2016","unstructured":"Syed YY (2016) Pitolisant: first global approval. Drugs 76:1313\u20131318. https:\/\/doi.org\/10.1007\/s40265-016-0620-1","journal-title":"Drugs"},{"key":"11582_CR18","doi-asserted-by":"publisher","first-page":"e2000165","DOI":"10.1002\/ardp.202000165","volume":"353","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, He G, Deng X et al (2020) Design, synthesis, and biological evaluation of novel nonimidazole histamine H3 receptor antagonists as potential antiseizure agents. Arch Pharm 353:e2000165. https:\/\/doi.org\/10.1002\/ardp.202000165","journal-title":"Arch Pharm"},{"key":"11582_CR19","doi-asserted-by":"publisher","unstructured":"Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs, NeuroRx 2. 541\u2013553. https:\/\/doi.org\/10.1602\/neurorx.2.4.541","DOI":"10.1602\/neurorx.2.4.541"},{"key":"11582_CR20","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/jm100112j","volume":"53","author":"C Bissantz","year":"2010","unstructured":"Bissantz C, Kuhn B, Stahl M (2010) A medicinal chemist\u2019s guide to molecular interactions. J Med Chem 53:5061\u20135084. https:\/\/doi.org\/10.1021\/jm100112j","journal-title":"J Med Chem"},{"key":"11582_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrd4486","volume":"14","author":"G Klebe","year":"2015","unstructured":"Klebe G (2015) Applying thermodynamic profiling in lead finding and optimization. Nat Rev Drug Discov 14:95\u2013110. https:\/\/doi.org\/10.1038\/nrd4486","journal-title":"Nat Rev Drug Discov"},{"key":"11582_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0022-3565(24)29209-0","volume":"299","author":"K Wieland","year":"2001","unstructured":"Wieland K, Bongers G, Yamamoto Y et al (2001) Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells. J Pharmacol Exp Ther 299:908\u2013914","journal-title":"J Pharmacol Exp Ther"},{"key":"11582_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2465","volume":"7","author":"RL Thurmond","year":"2008","unstructured":"Thurmond RL, Gelfand EW, Dunford PJ (2008) The role of histamine H1 and H4 receptors in allergic inflammation. Nat Rev Drug Discov 7:41\u201353. https:\/\/doi.org\/10.1038\/nrd2465","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"11582_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrd1631","volume":"4","author":"R Leurs","year":"2005","unstructured":"Leurs R, Bakker RA, Timmerman H, de Esch IJ (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat Rev Drug Discov 4(2):107\u2013120. https:\/\/doi.org\/10.1038\/nrd1631","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 4","key":"11582_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1528-1157.2001.0420s4007.x","volume":"42","author":"HJ Kupferberg","year":"2001","unstructured":"Kupferberg HJ (2001) Animal models used in the screening of antiseizure drugs. Epilepsia 42(Suppl 4):7\u201312. https:\/\/doi.org\/10.1046\/j.1528-1157.2001.0420s4007.x","journal-title":"Epilepsia"},{"issue":"9","key":"11582_CR26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/cells12091233","volume":"12","author":"W L\u00f6scher","year":"2023","unstructured":"L\u00f6scher W, White HS (2023) Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments. Cells 12(9):1233. https:\/\/doi.org\/10.3390\/cells12091233","journal-title":"Cells"},{"key":"11582_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","volume":"52","author":"W L\u00f6scher","year":"2011","unstructured":"L\u00f6scher W, Schmidt D (2011) Modern antiseizure drug development has failed to deliver: ways out of the current dilemma. Epilepsia 52:657\u2013678. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03024.x","journal-title":"Epilepsia"},{"key":"11582_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","volume":"131","author":"SC Baraban","year":"2005","unstructured":"Baraban SC, Taylor MR, Castro PA et al (2005) Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131:759\u2013768. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.11.031","journal-title":"Neuroscience"},{"key":"11582_CR29","doi-asserted-by":"crossref","first-page":"173205","DOI":"10.1016\/j.ejphar.2020.173205","volume":"881","author":"M Bhowmik","year":"2020","unstructured":"Bhowmik M, Khanam R, Vohora D (2020) Histamine H3 receptor as a potential therapeutic target for the treatment of epilepsy: current status and future perspectives. Eur J Pharmacol 881:173205","journal-title":"Eur J Pharmacol"},{"key":"11582_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","volume":"44","author":"M Ishiyama","year":"1997","unstructured":"Ishiyama M, Miyazono Y, Sasamoto K et al (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44:1299\u20131305. https:\/\/doi.org\/10.1016\/S0039-9140(97)00017-9","journal-title":"Talanta"},{"key":"11582_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","volume":"20","author":"BJ Jones","year":"1968","unstructured":"Jones BJ, Roberts DJ (1968) The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 20:302\u2013304. https:\/\/doi.org\/10.1111\/j.2042-7158.1968.tb09743.x","journal-title":"J Pharm Pharmacol"},{"key":"11582_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature04710","volume":"440","author":"MC Sanguinetti","year":"2006","unstructured":"Sanguinetti MC, Tristani-Firouzi M (2006) hERG potassium channels and cardiac arrhythmia. Nature 440:463\u2013469. https:\/\/doi.org\/10.1038\/nature04710","journal-title":"Nature"},{"key":"11582_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW et al (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409x(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"11582_CR34","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 32:1959\u20131972. https:\/\/doi.org\/10.1038\/jcbfm.2012.126","journal-title":"J Cereb Blood Flow Metab"},{"key":"11582_CR35","doi-asserted-by":"publisher","unstructured":"Sanders MP, McGuire R, Roumen L et al (2012) From the protein\u2019s perspective: the benefits and challenges of protein structure-based pharmacophore modeling, MedChemComm 3. 28\u201338. https:\/\/doi.org\/10.1039\/C1MD00210D","DOI":"10.1039\/C1MD00210D"},{"issue":"34","key":"11582_CR36","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.2174\/0929867328666210210121320","volume":"28","author":"M Veit-Acosta","year":"2021","unstructured":"Veit-Acosta M, de Azevedo Junior WF (2021) The impact of crystallographic data for the development of machine learning models to predict protein-ligand binding affinity. Curr Med Chem 28(34):7006\u20137022. https:\/\/doi.org\/10.2174\/0929867328666210210121320","journal-title":"Curr Med Chem"},{"key":"11582_CR37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/nar\/24.4.596","volume":"24","author":"M Jordan","year":"1996","unstructured":"Jordan M, Schallhorn A, Wurm FM (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24:596\u2013601. https:\/\/doi.org\/10.1093\/nar\/24.4.596","journal-title":"Nucleic Acids Res"},{"key":"11582_CR38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S1471-4892(01)00090-0","volume":"1","author":"SJ Hill","year":"2001","unstructured":"Hill SJ, Baker JG, Rees S (2001) Reporter-gene systems for the study of G-protein-coupled receptors. Curr Opin Pharmacol 1:526\u2013532. https:\/\/doi.org\/10.1016\/S1471-4892(01)00090-0","journal-title":"Curr Opin Pharmacol"},{"key":"11582_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0026-895X(24)12230-4","volume":"59","author":"C Liu","year":"2001","unstructured":"Liu C, Ma X, Jiang X et al (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420\u2013426","journal-title":"Mol Pharmacol"},{"key":"11582_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1081\/RRS-120014611","volume":"22","author":"M O\u2019Reilly","year":"2002","unstructured":"O\u2019Reilly M, Alpert R, Jenkinson S et al (2002) Identification of a histamine H4 receptor on human eosinophils\u2014role in eosinophil chemotaxis. J Recept Signal Transduct Res 22:431\u2013448. https:\/\/doi.org\/10.1081\/RRS-120014611","journal-title":"J Recept Signal Transduct Res"},{"issue":"4","key":"11582_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1528-1157.1978.tb04507.x","volume":"19","author":"RL Krall","year":"1978","unstructured":"Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19(4):409\u2013428. https:\/\/doi.org\/10.1111\/j.1528-1157.1978.tb04507.x","journal-title":"Epilepsia"},{"key":"11582_CR42","first-page":"2629","volume":"44","author":"EA Swinyard","year":"1985","unstructured":"Swinyard EA, Kupferberg HJ (1985) Antiepileptic drugs: detection, quantification, and evaluation. Fed Proc 44:2629\u20132633","journal-title":"Fed Proc"},{"key":"11582_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.vascn.2008.01.004","volume":"57","author":"MJ Winter","year":"2008","unstructured":"Winter MJ, Redfern WS, Hayfield AJ et al (2008) Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods 57:176\u2013187. https:\/\/doi.org\/10.1016\/j.vascn.2008.01.004","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"11582_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2174\/1386207054020813","volume":"8","author":"RM Eglen","year":"2005","unstructured":"Eglen RM (2005) Functional G protein-coupled receptor assays for primary and secondary screening. Comb Chem High Throughput Screen 8(4):311\u2013318. https:\/\/doi.org\/10.2174\/1386207054020813","journal-title":"Comb Chem High Throughput Screen"},{"key":"11582_CR45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0039-9140(97)00017-9","volume":"44","author":"M Ishiyama","year":"1997","unstructured":"Ishiyama M, Miyazono Y, Sasamoto K et al (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44:1299\u20131305. https:\/\/doi.org\/10.1016\/S0039-9140(97)00017-9","journal-title":"Talanta"},{"key":"11582_CR46","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","volume":"20","author":"BJ Jones","year":"1968","unstructured":"Jones BJ, Roberts DJ (1968) The quantitative measurement of motor incoordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 20:302\u2013304. https:\/\/doi.org\/10.1111\/j.2042-7158.1968.tb09743.x","journal-title":"J Pharm Pharmacol"},{"key":"11582_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pharmthera.2010.10.002","volume":"129","author":"GA Gintant","year":"2011","unstructured":"Gintant GA (2011) An evaluation of hERG current assay performance: translating preclinical safety studies to clinical QT prolongation. Pharmacol Ther 129:292\u2013309. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.10.002","journal-title":"Pharmacol Ther"},{"key":"11582_CR48","doi-asserted-by":"publisher","first-page":"114151","DOI":"10.1016\/j.jpba.2021.114151","volume":"202","author":"J Kang","year":"2021","unstructured":"Kang J, Won J, Fei X et al (2021) A sensitive analytical method for the determination of SG-SP1 in rat plasma by HPLC-MS\/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal 202:114151. https:\/\/doi.org\/10.1016\/j.jpba.2021.114151","journal-title":"J Pharm Biomed Anal"},{"key":"11582_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1124\/jpet.107.130294","volume":"325","author":"X Liu","year":"2008","unstructured":"Liu X, Chen C, Smith BJ (2008) Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 325:927\u2013939. https:\/\/doi.org\/10.1124\/jpet.107.130294","journal-title":"J Pharmacol Exp Ther"},{"key":"11582_CR50","doi-asserted-by":"publisher","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","volume":"10","author":"J Goedhart","year":"2020","unstructured":"Goedhart J, Luijsterburg MS (2020) VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci Rep 10:20560. https:\/\/doi.org\/10.1038\/s41598-020-76603-3","journal-title":"Sci Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11582-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11582-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11582-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:02:38Z","timestamp":1791266558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11582-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11582"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11582-7","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}